Skip to content
★ Sign in to follow
JR

J. Richard Iler

BioMETRX
Total declarations
32
Company
1
▲ Purchases (2 ops.)
€32k
▼ Sales (23 ops.)
€35k

Latest filing published 24 Sept 2008 for BioMETRX, €682.

Insider track record

Disclosed buys
2
Disclosed sells
23
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

  • BioMETRX 2 purchases · last 06 May 2008

J. Richard Iler: trading record in brief

J. Richard Iler appears in our data through filings on BioMETRX shares, published by SEC (Form 4). We count 32 filings; the first trade dates from 9 January 2007 and the latest from 23 September 2008.

In open-market terms, that means 2 purchases worth €32k on one side and 23 sales worth €35k on the other. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. 2008 to date brings 2 purchases and 12 sales.

Most recently, on 24 September 2008, the filings show an open-market sale worth €682 in BioMETRX. The clock since the last published purchase (6 May 2008) now reads 6,760 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 8 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to J. Richard Iler

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations31 total
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    1,000 USD0SEC
    5,000 shares@ US$0.20Common Stock $.001 par valueSEC:0001144204-08-054342:0
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    360 USD0SEC
    1,800 shares@ US$0.20Common Stock $.001 par valueSEC:0001144204-08-054342:1
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    969 USD0SEC
    5,100 shares@ US$0.19Common Stock $.001 par valueSEC:0001144204-08-054342:2
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    375 USD0SEC
    2,500 shares@ US$0.15Common Stock $.001 par valueSEC:0001144204-08-054342:3
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    2,600 USD0SEC
    20,000 shares@ US$0.13Common Stock $.001 par valueSEC:0001144204-08-054342:4
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    1,400 USD0SEC
    10,000 shares@ US$0.14Common Stock $.001 par valueSEC:0001144204-08-054342:5
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    2,600 USD0SEC
    20,000 shares@ US$0.13Common Stock $.001 par valueSEC:0001144204-08-054342:6
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    3,900 USD0SEC
    30,000 shares@ US$0.13Common Stock $.001 par valueSEC:0001144204-08-054342:7
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    840 USD0SEC
    6,000 shares@ US$0.14Common Stock $.001 par valueSEC:0001144204-08-054342:8
  • ◆
    Chief Financial OfficerExecutivesBioMETRX
    0SEC
    250,000 sharesCommon Stock $.001 par valueSEC:0001144204-08-054342:9
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    850 USD0SEC
    2,500 shares@ US$0.34Common Stock $0.001 par valueSEC:0001144204-08-033603:0
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    805 USD0SEC
    2,300 shares@ US$0.35Common Stock $0.001 par valueSEC:0001144204-08-033603:1
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    1,750 USD0SEC
    5,000 shares@ US$0.35Common Stock $0.001 par valueSEC:0001144204-08-033603:2
  • ▲
    Chief Financial OfficerExecutivesBioMETRX
    0SEC
    54,730 sharesCommon Stock $0.001 par valueSEC:0001144204-08-026339:1
    Canonical exit: 3 Aug 2008 (T+90)
  • ●
    Chief Financial OfficerExecutivesBioMETRX
    0SEC
    50,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-059101:0
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    1,290 USD0SEC
    1,500 shares@ US$0.86Common Stock $.001 par valueSEC:0001144204-07-054667:0
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    1,380 USD0SEC
    1,500 shares@ US$0.92Common Stock $.001 par valueSEC:0001144204-07-054667:1
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    1,350 USD0SEC
    1,500 shares@ US$0.90Common Stock $.001 par valueSEC:0001144204-07-054667:2
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    2,500 USD0SEC
    2,500 shares@ US$1.00Common Stock $.001 par valueSEC:0001144204-07-054667:3
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    2,450 USD0SEC
    2,500 shares@ US$0.98Common Stock $.001 par valueSEC:0001144204-07-054667:4
  • ●
    Chief Financial OfficerExecutivesBioMETRX
    0SEC
    50,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-054763:0
  • ●
    Chief Financial OfficerExecutivesBioMETRX
    0SEC
    80,000 sharesCommon Stock $.001 par valueSEC:0001144204-07-054763:1
  • ●
    Chief Financial OfficerExecutivesBioMETRX
    0SEC
    75,000 shares0Common Stock $.001 par valueSEC:0001144204-07-035668:0
  • ▼
    Chief Financial OfficerExecutivesBioMETRX
    5,775 USD0SEC
    3,300 shares@ US$1.75Common StockSEC:0001144204-07-026403:0
  • ◆
    Chief Financial OfficerExecutivesBioMETRX
    99,750 USD0SEC
    95,000 shares@ US$1.05Common Stock $.001 par valueSEC:0001144204-07-019538:0

25 of 31 declarations